Nuwellis Inc Total Assets
Nuwellis Inc total assets. Based on the latest financial reports, Nuwellis Inc (NUWE) holds total assets worth $9.13 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see NUWE company net worth for the company's overall valuation and market capitalisation.
Total Assets of Nuwellis Inc (2002–2025)
Total assets of Nuwellis Inc from 2002 to 2025. This chart illustrates how Nuwellis Inc's total assets have evolved over time, based on quarterly financial data. See Nuwellis Inc share price for real-time trading data and today's change.
Nuwellis Inc - Asset Composition Analysis
Nuwellis Inc Total Assets Breakdown (December 2025)
Nuwellis Inc total assets breakdown as of December 2025. Nuwellis Inc's total assets of $9.13 Million consist of 84.8% current assets and 15.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 17.7% |
| Accounts Receivable | $1.49 Million | 24.4% |
| Inventory | $1.91 Million | 31.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2002–2025)
This chart illustrates how Nuwellis Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Nuwellis Inc's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nuwellis Inc's current assets represent 84.8% of total assets in 2025, a decrease from 92.6% in 2002.
- Cash Position: Cash and equivalents constituted 17.7% of total assets in 2025, down from 91.3% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
- Asset Diversification: The largest asset category is inventory at 31.2% of total assets.
Nuwellis Inc Competitors by Total Assets
Key competitors of Nuwellis Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Nuwellis Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.97 | 2.16 | 8.62 |
| Quick Ratio | 1.54 | 1.64 | 7.88 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.89 Million | $4.52 Million | $28.93 Million |
Nuwellis Inc - Advanced Valuation Insights
This section examines the relationship between Nuwellis Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.18 |
| Latest Market Cap to Assets Ratio | 0.40 |
| Asset Growth Rate (YoY) | -38.0% |
| Total Assets | $6.12 Million |
| Market Capitalization | $2.46 Million USD |
Valuation Analysis
Below Book Valuation: The market values Nuwellis Inc's assets below their book value (0.40x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Nuwellis Inc's assets decreased by 38.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Nuwellis Inc (2002–2025)
The table below shows the annual total assets of Nuwellis Inc from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $6.12 Million | -37.98% |
| 2024-12-31 | $9.86 Million | +0.96% |
| 2023-12-31 | $9.77 Million | -60.40% |
| 2022-12-31 | $24.67 Million | -18.88% |
| 2021-12-31 | $30.42 Million | +51.99% |
| 2020-12-31 | $20.01 Million | +257.23% |
| 2019-12-31 | $5.60 Million | -36.17% |
| 2018-12-31 | $8.78 Million | -52.45% |
| 2017-12-31 | $18.45 Million | +147.02% |
| 2016-12-31 | $7.47 Million | -69.59% |
| 2015-12-31 | $24.57 Million | -24.10% |
| 2014-12-31 | $32.37 Million | -41.39% |
| 2013-12-31 | $55.23 Million | +267.32% |
| 2012-12-31 | $15.04 Million | +102.34% |
| 2011-12-31 | $7.43 Million | +66.06% |
| 2010-12-31 | $4.47 Million | 0.00% |
| 2009-12-31 | $4.47 Million | +125.67% |
| 2008-12-31 | $1.98 Million | -79.64% |
| 2007-12-31 | $9.74 Million | +36.98% |
| 2006-12-31 | $7.11 Million | +49.65% |
| 2005-12-31 | $4.75 Million | -37.83% |
| 2004-12-31 | $7.64 Million | +442.13% |
| 2003-12-31 | $1.41 Million | +9.80% |
| 2002-12-31 | $1.28 Million | -- |
About Nuwellis Inc
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly… Read more